This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan B. Vatz, MD; Shirley E. Kellie, MD
American Medical Association Chicago, Ill

JAMA. 1991;265(14):1824-1825.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Colditz et al¹ categorized estrogen exposure into three groups: never users, current users, and past users. Past users are further stratified on duration of use and years since last use, and current users on duration of use. Based on these measures of estrogen exposure, the investigators note that "the past users of replacement estrogen were not at an increased risk [of breast cancer]..., including even those with more than 10 years of use (relative risk [RR] after adjustment for established risk factors, 0.70; 95% confidence interval [CI], 0.45 to 1.10)." This adjusted RR of 0.70 for past users with 10 or more years of use, however, appears to be inconsistent with data presented in Table 3 of the article by Colditz et al, in which the 0.70 RR refers to the adjusted RR for past users who stopped using estrogen 10 or more years ago. The . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?